切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - SMARCA4 - Voltage-gated Sodium (NaV) Channels - CSF-1R

21件产品中的 1-10

页面
每页
清除全部
  1. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: 酪氨酸激酶抑制剂(TKI)
      ≥10.62 mg/mL
      ≥168.2 mg/mL
  2. BLZ945
    B4899 BLZ945
     1 Citation
    Target: CSF-1R
    Summary: CSF-1R激酶抑制剂
      ≥19.9 mg/mL
      insoluble in H2O
  3. ProTx II
    B5515 ProTx II
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: NaV1.7通道阻断剂
      Soluble to 1 mg/mL
  4. PFI 3
    B7744 PFI 3
    Target: Protein polybromo-1|SMARCA4|SMARCA2
    Summary: Polybromo 1和SMARCA4抑制剂
      ≥15.15 mg/mL
      insoluble in H2O
  5. Quinidine
    B7590 Quinidine
    中文名: 奎尼丁
    Target: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)
    Summary: 降低Na+和K+通道电流
      ≥11.95 mg/mL
      insoluble in H2O
  6. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  7. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  8. Bupivacaine HCl
    B1420 Bupivacaine HCl
    中文名: 盐酸布比卡因
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 麻醉药
      ≥10.25 mg/mL
      ≥16.23 mg/mL
  9. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  10. Phenytoin sodium
    B2272 Phenytoin sodium
    中文名: 苯妥英钠
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 钠通道稳定剂
      ≥11.55 mg/mL
      insoluble in H2O

21件产品中的 1-10

页面
每页